Cumulus Neuroscience

company

About

Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform.

  • Belfast,Belfast,United Kingdom
  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
£6M
Industries
Health Care
Founded date
Jan 1, 2015
Number Of Employee
11 - 50
Operating Status
Active

Cumulus Neuroscience develops an AI-based digital biomarker platform to aid in the resolution of the most pressing healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience's platform is intended to provide the critical data and insight required for more rapid, robust, and cost-effective clinical trials that improve patient access to new therapies. The platform's novel insights change the future of clinical trials in brain disorders, allowing life-changing therapies to reach patients faster and more affordably.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
£6M
Cumulus Neuroscience has raised a total of £6M in funding over 2 rounds. Their latest funding was raised on May 4, 2021 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 4, 2021 Series Unknown £6M 3 Dementia Discovery Fund Detail

Investors

Number of Lead Investors
Number of Investors
1
3
Cumulus Neuroscience is funded by 3 investors. Dementia Discovery Fund and UK Future Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Dementia Discovery Fund Yes Series Unknown
UK Future Fund Series Unknown
LifeArc Series Unknown

Employee Profiles

Number of Employee Profiles
4
Cumulus Neuroscience has 4 current employee profiles, including Executive Ronan Cunningham
Executive
Executive
Executive